Literature DB >> 23529023

Clinical and imaging characteristics of dementia in multiple system atrophy.

Han-Joon Kim1, Beom S Jeon, Young Eun Kim, Ji-Young Kim, Yu Kyeong Kim, Chul-Ho Sohn, Ji Young Yun, Seun Jeon, Jong-Min Lee, Jee-Young Lee.   

Abstract

BACKGROUND: Recent reports show that dementia occurs in 5-26% of multiple system atrophy (MSA) patients. However, the structural or pathological correlates of dementia in MSA are unclear yet.
METHODS: Of 152 patients with MSA, 59 fulfilled the criteria of probable MSA and 9 (15%) had dementia. Six of those patients and 9 without dementia, in addition to 10 controls, were included. All subjects underwent clinical evaluation including UMSARS, neuropsychological examinations, 3T-MRI, and Pittsburgh Compound B (PIB) PET imaging. The cortical thickness was assessed using surface-based morphometry.
RESULTS: Age and disease duration were similar between MSA with dementia and without dementia, while motor disability was more severe in MSA with dementia. In neuropsychological tests, attention, visuospatial function, and language function were impaired in MSA with dementia. Mean PIB binding was similar among the three groups. Cortical thickness was reduced in precuneus/cuneus, uncus, and posterior cingulate in MSA with dementia compared to the controls, and in parahippocampal and lingual cortices compared to MSA without dementia.
CONCLUSIONS: Dementia was found in 15% of the probable MSA patients, which was similar to those reported in previous studies. It appears that amyloid pathology has limited role in dementia in MSA, although some patients had increased cortical amyloid burden. Cortical thinning in MSA-D was observed in areas where cortical thinning was reported in Alzheimer disease or Parkinson disease dementia, but its pathological relevance is unclear. The neuropathological processes leading to the development of dementia in MSA appears to be multifactorial and heterogenous.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529023     DOI: 10.1016/j.parkreldis.2013.02.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

Review 1.  Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.

Authors:  Iva Stankovic; Florian Krismer; Aleksandar Jesic; Angelo Antonini; Thomas Benke; Richard G Brown; David J Burn; Janice L Holton; Horacio Kaufmann; Vladimir S Kostic; Helen Ling; Wassilios G Meissner; Werner Poewe; Marija Semnic; Klaus Seppi; Atsushi Takeda; Daniel Weintraub; Gregor K Wenning
Journal:  Mov Disord       Date:  2014-04-18       Impact factor: 10.338

Review 2.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

3.  Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants.

Authors:  Santosh Kumar Dash; Albert Stezin; Tejashree Takalkar; Lija George; Nitish L Kamble; M Netravathi; Ravi Yadav; Keshav J Kumar; Madhura Ingalhalikar; Jitender Saini; Pramod Kumar Pal
Journal:  Eur Radiol       Date:  2018-07-04       Impact factor: 5.315

Review 4.  Role of Magnetic Resonance Imaging in the Diagnosis of Multiple System Atrophy.

Authors:  Han-Joon Kim; Beomseok Jeon; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2016-07-28

5.  Unraveling the potential co-contributions of cerebral small vessel vasculopathy to the pathogenesis of Alzheimer's dementia.

Authors:  Jodi D Edwards; Joel Ramirez; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2015-07-10       Impact factor: 6.982

6.  The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy.

Authors:  Bei Cao; Bi Zhao; Qian-Qian Wei; Ke Chen; Jing Yang; RuWei Ou; Ying Wu; Hui-Fang Shang
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 7.  Amyloid PET imaging: applications beyond Alzheimer's disease.

Authors:  Ana M Catafau; Santiago Bullich
Journal:  Clin Transl Imaging       Date:  2015-01-21

8.  Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.

Authors:  Hae Won Kim; Minyoung Oh; Jungsu S Oh; Seung Jun Oh; Sang Ju Lee; Sun Ju Chung; Jae Seung Kim
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

9.  REM Sleep Behavior Disorder Is Not Associated with a More Rapid Cognitive Decline in Mild Dementia.

Authors:  Luiza Chwiszczuk; Monica Haraldseid Breitve; Kolbjørn Brønnick; Michaela D Gjerstad; Minna Hynninen; Dag Aarsland; Arvid Rongve
Journal:  Front Neurol       Date:  2017-08-07       Impact factor: 4.003

Review 10.  Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Authors:  Usman Saeed; Jordana Compagnone; Richard I Aviv; Antonio P Strafella; Sandra E Black; Anthony E Lang; Mario Masellis
Journal:  Transl Neurodegener       Date:  2017-03-28       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.